Drug Products and Medical Devices for Allergology, Infectious Disease and Inner Ear Indications

The legacy programs of Altamira comprise Bentrio^®, an “over-the-counter” (i.e. prescription free) nasal spray for protection against airborne particles such as allergens or viruses, and various inner ear therapeutics for the treatment of vertigo, hearing loss or tinnitus. As part of its strategic repositioning around RNA delivery, Altamira is seeking to out-license or divest the legacy programs in the course of 2023.